Torrie Fields, MPH
Founder & Chief Executive Officer
Torrie Fields is the Founder and CEO of Votive Health. Prior to Votive Health, Fields served as Head of Palliative Care at Blue Shield of California and Cambia Health Solutions and worked as a management and actuarial consultant for health plans, purchasers, and academic centers evaluating the impact of palliative care on achieving the Institute for Healthcare Improvement’s Triple Aim. She has led development of highly successful palliative care initiatives including benefit design, case management, caregiver support, medical home development and policy and engagement efforts. Fields’ experience has encompassed work as an economist and health services researcher in a variety of settings, including health plans, health delivery systems and local and federal health departments. She has a deep expertise in health policy development and implementation, translating evidence-based research into legislative concepts and regulatory change.
Fields holds a Masters in Public Health focused in Health Management & Policy from Oregon Health and Sciences University, a B.S.in Sociology from Portland State University, a B.A. in Communication Theory from the University of California, San Diego, and a Certificate in Gerontology from Portland Community College.
Csaba Mera, MD, FAAP
Chief Medical Officer
As Chief Medical Officer for Votive Health, Csaba Mera brings twenty-three years experience as a practicing clinician and twenty years as a physician executive. Having worked in both provider and payer capacities, he is uniquely suite to manage all aspects of medical management, cost management and healthcare quality. He is an accomplished, experienced, outcomes-driven healthcare leader with skills built on a foundation of quality, evidence-based medicine, cost efficiency, innovation and performance excellence.
Csaba has built innovative medical management health plan programs with robust returns on investment for commercial, Medicaid and Medicare lines. In addition to significant success as a health plan physician executive, Csaba has been a key consultant to Fortune 500/100 companies, including Time Warner, Dow Chemical, Xerox, AT&T and American Airlines.
Csaba has successfully led a number of healthcare organizations through URAC, JCAHO and NCQA accreditation at the highest levels. As a Malcolm Baldrige National Quality Award Examiner, he has engaged with the nation’s highest quality healthcare organizations, annually recognized by the President of the United Sates and the Secretary of Commerce.
Head of Product
Geoffrey Clapp leads the product and technical operations for Votive Health. Clapp is a technologist turned healthcare entrepreneur, executive, and investor with a 20+ year track record of building impactful companies that have changed healthcare delivery. A pioneer of the digital health movement, he co-founded and led engineering and operations for the world’s largest remote patient monitoring company, which was acquired by Bosch and then helped get Rock Health off the ground as the premier incubator for digital health innovation. More recently, he has partnered with the Mayo Clinic on innovation initiatives, served as Chief Product Officer for a kidney care startup, and served as an investor and advisor to a wealth of digital health companies spanning various stages.
A multi-time CEO and CTO, he is an expert in patient-centered design and merging technology, product development, and operations to solve the world's largest healthcare challenges with a long track record of highly successful implementations.
Tres Cossaboom joined Votive Health as VP, Finance in August of 2020, supporting the vision of Votive's technology-enabled services.
Tres comes to Votive Health with ten years of finance experience in the venture-backed and start-up space. In addition to the years he spent working to build firms from within, he also spent 5 years at Propeller Industries, a leading CFO services company, where he wore many hats. While with Propeller, he worked on over 100 clients, in 11 major industry verticals, allowing him an impressive breadth of experience.
Tres holds a master's degree in finance from Louisiana State University and a bachelor's degree in finance also from Louisiana State University.
Sid Khanijou JD, MPH
General Counsel & VP, Network Strategy
Sid Khanijou is General Counsel & VP, Network Strategy at Votive Health. He has spent his career seeking to transform the healthcare industry and brings multidisciplinary experience having worked at physician advocacy organizations, pharmaceutical companies, local government, and health plans. Sid routinely negotiates complex commercial contracts, provides cutting-edge strategic counsel, and proactively advises clients on opportunities and risk with an eye towards the industry’s evolving regulatory landscape. He understands the incentives that drive healthcare decision-making, and helps institutions and policymakers develop innovative payment models that align value and create the best outcomes for payers, providers, and patients.
Prior to Votive, Sid was at Cambia Health Solutions where he served as Senior Associate General Counsel to lead support of transactional, regulatory, and litigation matters related to Cambia's provider and pharmacy benefit manager (PBM) relationships, which included negotiating value-based (population health) arrangements, warranty and rebate arrangements, and other network agreements with health systems, management services organizations and other risk-bearing intermediaries. He also worked as counsel at Aetna where he provided broad legal support for its domestic (Medicare and Retiree Markets) and international (Aetna International) business units and insurance operations.
Sid holds a juris doctor (JD) from DePaul University College of Law, a master of public health (MPH) from Harvard School of Public Health, and a bachelor's degree (BA) in cognitive science from Occidental College.
Dan Lamoree is the VP of Technology of Votive Health where he implements and manages the technology solutions to support and enable Votive Health.
Dan joins Votive Health with 15 years of experience in institutional research and information technology where he was most recently the Sr. Director of Information Technology and was responsible for all aspects of IT at an educational non-profit providing a suite of data science tools for the California Community College Chancellor's Office. Dan has won multiple statewide awards for innovation, planning, and research. Additionally, he was hand-picked by the California Governor's Office to serve on two statewide subcommittees lending expertise and guidance for the California Cradle-to-Career Data System Act passed by the California State Legislature. Dan was the lead developer and data architect for the implementation of AB 705.
Dan holds a bachelor's of science in psychology and bachelor's of arts in philosophy from California Polytechnic State University.
Directors and Advisors
Dan Gebremedhin, MD
Dan Gebremedhin, MD is a Partner at Flare Capital Partners and serves on the Board of Flare portfolio companies Eden Health and Somatus. Prior to joining Flare Capital, Dan served as a Medical Director at the Harvard Pilgrim Health Plan. Dan spent over 8 years as a practicing Internal Medicine Physician on the Faculty of the Massachusetts General Hospital and Instructor in Medicine at Harvard Medical School, after completing Internal Medicine Residency at the Massachusetts General Hospital in 2010. Dan served on Massachusetts Governor Charlie Baker’s Board of Nursing Home Administrators from 2016 to 2020. He has served as a Senior Health Policy Advisor for the Campaigns of Governor Charlie Baker, Congressman Joseph Kennedy III and Congressman Jake Auchincloss. Dan earned a B.S. from the University of California, San Diego, an M.D. from the Morehouse School of Medicine, and an M.B.A. from the Harvard Business School.
David A. Jones, Jr.
David A. Jones, Jr. is one of the leading venture capitalists in mid-America and a well-respected voice in healthcare business and innovation. He founded Chrysalis in 1993, after realizing that the absence of resident venture capital managers in Mid-America represented an opportunity to find and partner with promising growth companies in the region. He currently focuses primarily on healthcare investing and chairs the management company and funds’ investment committees.
David is active in civic and charitable affairs on both national and local levels. Recognizing the critical role education plays in catalyzing American innovation and competitiveness, as well as its potential to improve public health, David served as an elected member of the Jefferson County (KY) Board of Education (2012-2016) and as its chair for two years. He is a director of the Humana Foundation, which focuses on social determinants of health as a means of enhancing health equity, and of the C.E. & S. Foundation, which focuses on improving access and outcomes in P-16 education.
David has served as adjunct professor at Georgetown University in Washington, DC (constitutional and foreign affairs law) and at University of Louisville (entrepreneurship), and is currently an adjunct professor of innovation at Bellarmine University in Louisville. David lectures frequently in Chrysalis’ region on topics related to venture capital and the changing healthcare industry.
Bob Saunders is a General Partner of OCA Ventures and chairs its healthcare investing activity. He represents OCA on the boards of mPulse, ReGroup Therapy and HealthiPass. He is also a Co-Founder and Chairman of XLerateHealth, a healthcare accelerator in Louisville, KY.
Prior to OCA, Bob was a Senior Managing Director and General Partner at Chrysalis Ventures (Louisville) from 1997 to 2009 and served as a Senior Advisor to Chrysalis from 2009-2010. He was also co-founder of Saunders Murdock and Associates, a life science “super-angel” investor, and a Senior Managing Director at Providian Capital Management from 1993-1997. He began his career in business strategy consulting and worked with both The Boston Consulting Group and Bain & Co.
Over the last 30 years, he has invested in several dozen startup companies and has mentored 100+ startups.
Bob received a B.A. from Stanford University, an M.Sc. from the London School of Economics, and an M.A. from Harvard University. Bob is both a Fulbright Scholar and a Marshall Scholar.
Mark Morse, MBA
Mark Morse is a technology advisor to Votive Health where he provides strategic input on technology platforms, tools and analytics.
In his current role, Mark serves as CEO at Enclara Pharmacia. Enclara is the nation’s largest hospice PBM providing services to over 450 hospice organizations and their patients across the country. In his role, Mark is responsible for all aspects of the company’s strategy development and execution, operational performance, sales and P&L.
Prior to his role as CEO, Mark held several roles in the company include leading Pharmacy Service Operations, PBM sales and client services of integrated medical/Rx business, Corporate Sales Director for National & Major Account and product innovation work focused on consumer driven solutions.
Prior to joining Humana in 2001, Mark spent six years with UnitedHealth Group serving as the business owner for its consumer portal and operations director for health plan and systems migration.
Actuarial and Pricing Advisor
Tom Wortman is a financial advisor to Votive Health, where he provides strategic input for the Company’s financial, actuarial, and data analytics functions. Tom is committed to achieving Votive Health’s vision of vastly improving care for people with serious illness by providing a higher quality experience for members, their families, providers and health plans.
Tom brings a wealth of health care industry knowledge and leadership to Votive. Prior to joining the company, he held various Actuarial/Financial leadership roles with Cambia Health Solutions / Regence Blue Cross Blue Shield, the last several years as VP of Government Programs Actuarial. Tom was a consultant at Milliman USA prior to joining Cambia. Tom holds a Bachelor’s of Science in Mathematics from the University of Idaho.